Lv5
1174 积分 2023-04-06 加入
FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia
23天前
已关闭
Integrated safety summary of FOCUS 1 and FOCUS 2 trials: Phase III randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with community-acquired pneumonia
23天前
已完结
Ceftaroline fosamil versus ceftriaxone for the treatment of Asian patients with community-acquired pneumonia: a randomised, controlled, double-blind, phase 3, non-inferiority with nested superiority trial
23天前
已完结
Rational Multimodal Analgesia for Perioperative Pain Management
24天前
已完结
EULAR/ACR classification criteria for SLE
2个月前
已完结
EAACI/GA²LEN/EDF/WAO guideline: management of urticaria
4个月前
已完结
EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria
4个月前
已完结
Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study
4个月前
已完结
Urticaria
5个月前
已完结
Prevalence and risk factors of chronic urticaria in China: A nationwide cross‐sectional study
5个月前
已完结
皖公网安备34019202002308
